Skip to content
10-Q

Quarterly Report

PROCEPT BioRobotics Corporation PRCT

0001588978-26-000022

← back to feed
Filed
Apr 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 24, 2026 56.92M sh
Shares Diluted Q1 2026 · Mar 31, 2026 56.51M sh
Shares Diluted Q1 2026 · Mar 31, 2025 54.92M sh
Capex Q1 2026 · Mar 31, 2026 $2.91M
Capex Q1 2026 · Mar 31, 2025 $1.84M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$38.13M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$16.98M
Long Term Debt Q1 2026 · Mar 31, 2026 $51.66M
Long Term Debt Q1 2026 · Dec 31, 2025 $51.62M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $245.64M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $286.5M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $316.21M
Stockholders Equity Q1 2026 · Mar 31, 2026 $347.67M
Stockholders Equity Q1 2026 · Dec 31, 2025 $365.87M
Stockholders Equity Q1 2026 · Mar 31, 2025 $389.16M
Stockholders Equity Q1 2026 · Dec 31, 2024 $402.22M
Current Liabilities Q1 2026 · Mar 31, 2026 $63.64M
Current Liabilities Q1 2026 · Dec 31, 2025 $65.8M
Total Liabilities Q1 2026 · Mar 31, 2026 $139.4M
Total Liabilities Q1 2026 · Dec 31, 2025 $142.21M
Current Assets Q1 2026 · Mar 31, 2026 $428.03M
Current Assets Q1 2026 · Dec 31, 2025 $450.38M
Total Assets Q1 2026 · Mar 31, 2026 $487.06M
Total Assets Q1 2026 · Dec 31, 2025 $508.08M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.56
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.45
Eps Basic Q1 2026 · Mar 31, 2026 −$0.56
Eps Basic Q1 2026 · Mar 31, 2025 −$0.45
Sga Expense Q1 2026 · Mar 31, 2026 $65.09M
Sga Expense Q1 2026 · Mar 31, 2025 $55.2M
Rd Expense Q1 2026 · Mar 31, 2026 $21.47M
Rd Expense Q1 2026 · Mar 31, 2025 $16.4M
Net Income Q1 2026 · Mar 31, 2026 −$31.64M
Net Income Q1 2026 · Mar 31, 2025 −$24.74M
Operating Income Q1 2026 · Mar 31, 2026 −$32.61M
Operating Income Q1 2026 · Mar 31, 2025 −$27.44M
Gross Profit Q1 2026 · Mar 31, 2026 $53.95M
Gross Profit Q1 2026 · Mar 31, 2025 $44.16M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $29.19M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $25M
Revenue Q1 2026 · Mar 31, 2026 $83.13M
Revenue Q1 2026 · Mar 31, 2025 $69.16M